SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-062805
Filing Date
2018-10-18
Accepted
2018-10-18 17:01:41
Documents
2
Period of Report
2018-10-18

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 4104
2 EX-24.1 ex-24d1.htm EX-24.1 8639
  Complete submission text file 0001104659-18-062805.txt   14138
Mailing Address C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106 CEDAR KNOLLS NJ 07927
Business Address
Einhorn Andrew J. (Reporting) CIK: 0001560685 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 181128812

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations